AirSculpt Technologies (NASDAQ:AIRS), a national provider of body contouring procedures, reported its fourth-quarter and full-year fiscal 2025 financial results.
Fourth-quarter revenue totaled $33.4 million, while full-year revenue reached $151.8 million.
Case volume decreased approximately 15% year-over-year to 2,604 procedures in the fourth quarter and 11,852 procedures for the full year.
For the full year, adjusted EBITDA was $15.1 million and the net loss was $11.7 million.
As of December 31, 2025, the company held $8.4 million in cash with gross debt of approximately $56 million.
Subsequent to year-end, AirSculpt raised $14.8 million through an at-the-market (ATM) equity offering and reduced debt to approximately $45 million.
Looking ahead, the company provided fiscal 2026 guidance expecting revenue between $151 million and $157 million and adjusted EBITDA between $15 million and $17 million.